| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.11 | 0.6 |